Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

FDA approves Axsome (dextromethorphan + bupropion)

Posted by SLS on August 24, 2022, at 11:11:16

Hi, All.

The FDA approved Axsome (dextromethorphan + bupropion) on August 19.

"On 19 August, the US Food and Drug Administration (FDA ) approved Axsome Therapeutics (US) Auvelity (dextromethorphan + bupropion) for the treatment of major depressive disorder (MDD) in adults. Auvelity is the first orally administered product with a novel mechanism of action (MOA) to enter the MDD market in more than 60 years. The dextromethorphan component targets the N-methyl D-aspartate (NMDA) receptor and the sigma-1 receptor in the brain, while the bupropion component acts to increase levels of dextromethorphan in the blood."

"The drug, Auvelity, is a new class of treatment that reduces the symptoms of depression as early as one week, giving it a potential edge over older antidepressants, which can take up to six weeks to show effect."

- Scott

Some see things as they are and ask why.
I dream of things that never were and ask why not.

The only thing necessary for the triumph of evil is that good men do nothing.




Post a new follow-up

Your message only Include above post

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.


Start a new thread

Google www
Search options and examples
[amazon] for

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:SLS thread:1120470